Publication | Closed Access

A novel flavonoid from Fissistigma cupreonitens, 5‑hydroxy‑7,8‑dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance

Molecular PharmacologyMedicinal ChemistryChemoprevention StrategyBiochemistryCancer Multi-drug ResistanceMedicineNatural SciencesAnti-cancer AgentHuman P-glycoproteinPharmacologyNovel FlavonoidDrug Discovery